Microbot Medical
MBOT
70 hedge funds and large institutions have $22.8M invested in Microbot Medical in 2025 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 13 closing their positions.
96% more call options, than puts
Call options by funds: $1.94M | Put options by funds: $991K
46% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 13
13% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 15
4% more funds holding
Funds holding: 67 → 70 (+3)
0.02% less ownership
Funds ownership: 16.98% → 16.96% (-0.02%)
17% less capital invested
Capital invested by funds: $27.4M → $22.8M (-$4.58M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.34M |
| 2 |
DnB Asset Management
Oslo,
Norway
|
+$1.03M |
| 3 |
BlackRock
New York
|
+$897K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$636K |
| 5 |
6CM
683 Capital Management
New York
|
+$606K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Heights Capital Management
San Francisco,
California
|
-$2.69M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$632K |
| 3 |
Millennium Management
New York
|
-$90K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$83K |
| 5 |
EFI
EHP Funds Inc
Toronto,
Canada
|
-$77.6K |
MBOT Hedge Fund Activity: Q4 2025 in Review
70 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2025, worth a combined $22.8M — down 17% from $27.4M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new MBOT positions and 13 closed out — a net gain of 6 holders — while 17 added to existing stakes and 15 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.34M. The largest seller was Heights Capital Management, exiting entirely with an estimated $2.69M sold.
- 70 institutional investors held Microbot Medical (MBOT) as of Q4 2025, up from 67 in Q3 2025.
- Funds reported $22.8M of Microbot Medical stock for Q4 2025, down 17% quarter-over-quarter.
- 19 funds opened new Microbot Medical positions in Q4 2025 and 13 closed out, a net change of +6 holders.
- The largest Microbot Medical buyer in Q4 2025 was Vanguard Group, an estimated $2.34M added.
- The largest Microbot Medical seller in Q4 2025 was Heights Capital Management, an estimated $2.69M sold.
Based on aggregated 13F filings for Q4 2025.